NCT01150461View on ClinicalTrials.gov

Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

losartan

Losartan 50 mg b.i.d

DRUG

placebo

Placebo b.i.d.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01150461 - Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter